Elanco Animal Health Inc [ELAN] stock is trading at $14.30, up 2.73%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ELAN shares have gain 6.24% over the last week, with a monthly amount glided 19.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on December 09, 2024, when UBS initiated its Buy rating and assigned the stock a price target of $18. Previously, Leerink Partners started tracking the stock with Market Perform rating on December 02, 2024, and set its price target to $14. On September 19, 2024, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $15 on the stock. Stifel upgraded its rating to a Buy and increased its price target to $20 on January 05, 2024. Jefferies initiated its recommendation with a Buy and recommended $17 as its price target on December 19, 2023. Morgan Stanley upgraded its rating to Overweight for this stock on December 15, 2023, but kept the price target unchanged to $16. In a note dated December 07, 2023, Exane BNP Paribas initiated an Outperform rating and provided a target price of $18 on this stock.
Elanco Animal Health Inc [ELAN] stock has fluctuated between $8.02 and $18.80 over the past year. Currently, Wall Street analysts expect the stock to reach $11.5 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $14.30 at the most recent close of the market. An investor can expect a potential drop of -19.58% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
Elanco Animal Health Inc [NYSE:ELAN] reported sales of 4.43B for the trailing twelve months, which represents a drop of -1.00%. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.06 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Elanco Animal Health Inc’s Current Ratio is 2.71. Also, the Quick Ratio is 1.46, while the Cash Ratio stands at 0.38. Considering the valuation of this stock, the price to sales ratio is 1.60, the price to book ratio is 1.12 and price to earnings (TTM) ratio is 19.08.
Transactions by insiders
Recent insider trading involved Kurzius Lawrence Erik, Director, that happened on Mar 07 ’25 when 10000.0 shares were purchased. Director, Kurzius Lawrence Erik completed a deal on Mar 11 ’25 to buy 10000.0 shares. Meanwhile, Director HOOVER R DAVID bought 25000.0 shares on Mar 05 ’25.
